HOME INFUSION THERAPY MARKET ANALYSIS

Home Infusion Therapy Market Size and Trends

The global home infusion therapy market is estimated to be valued at USD 24.51 Bn in 2024 and is expected to reach USD 38.4 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.6% from 2024 to 2031.

To learn more about this report, request sample copy

The home infusion therapy market is expected to witness high growth rate over the forecast period owing to the increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases. Rising geriatric population suffering from these conditions coupled with growing preference of patients to get treatment administered at home instead of hospitals or long-term care centers is a key factor expected to drive the demand for home infusion therapy. Additionally, rising health care costs have compelled patients to opt for low-cost treatment settings like home care which is further expected to support the market growth in the coming years.

Growing Prevalence of Chronic Diseases

There has been a consistent rise in the number of patients suffering from chronic diseases across the globe. Some of the most common chronic diseases include cancer, diabetes, cardiovascular diseases, respiratory diseases, and autoimmune disorders. According to experts, numerous factors such as increasing sedentary lifestyles, unhealthy diets, rising stress levels, pollution, and increasing geriatric population are contributing to this trend. Chronic diseases require long term treatment and management and many a times patients require medications and therapies to be administered at home. Home infusion therapy market provides an effective solution for patients with chronic diseases to receive intravenous medication, nutrition, or other therapies in the comfort of their home. This helps in improving their quality of life by relieving them from frequent hospital visits. With a greater number of people being diagnosed with chronic diseases each year, the demand for alternative treatment options like home infusion therapy market is growing worldwide. For instance, according to data from the World Health Organization (WHO) in the Global Tuberculosis Report 2021, the majority of tuberculosis cases were concentrated in the WHO regions of South-East Asia (43%), Africa (25%), and the Western Pacific (18%). Similarly, based on WHO data from 2021, Sub-Saharan Africa bears a significant burden of malaria, with 95% of all infections occurring in this region, indicating a continued heavy impact from the disease. Consequently, the increasing burden of various infectious diseases across developed and emerging markets is expected to propel growth in the market under study.

Advancements in Home Infusion Technologies

Over the years, significant developments have been made in home infusion technologies which have made therapy more viable, safe, and convenient for patients. The development of small, portable infusion pumps and devices have allowed complex drug regimens and treatments to be administered outside of hospitals. These pumps are programmable, lightweight, and equipped with alarms to prevent any medication errors. Advancements in catheter and vascular access technologies have minimized the risks of infections and other complications associated with the delivery of infused medicines at home. This has encouraged more physicians to prescribe infusion treatments at home. New innovations in connectivity technologies are also allowing remote monitoring of patients via mobile apps and internet. Caregivers can now seamlessly track patients' vital signs and infusion status from a distance. Emerging technologies like artificial intelligence and robotics are further enhancing the reliability and ease of use of home infusion equipment. Such technological breakthroughs have addressed various concerns around home infusion and built confidence among doctors to transition eligible patients from hospital care to homes. This serves as a major driver enabling growth in home infusion therapy adoption.